YOLFTbeta
09

Jw Holdings

096760 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

3,705.00KRW-5.00 (-0.13%)

Price History

Full chart

Market Stats

Previous Close3,710.00
Open3,640.00
Day Range3,635.00 – 3,735.00
52-Week Range2,989.20 – 4,720.00
Volume56.95K
Market Cap295.44B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield4.94%
Beta0.58
50-Day Avg4,088.60
200-Day Avg3,969.88

About

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair care, beauty care, and other cosmetics products; infant care system, gynecological examining table, sterilizer equipment, diagnostic imaging equipment, operating room equipment, non-PVC film, tube, and empty bag, and health supplements. In addition, the company provides integrated services for IV solution. JW Holdings Corporation was founded in 1945 and is based in Gwacheon-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Kyung-Ha Lee
  • Employees114
  • HeadquartersJW Gwacheon Tower, Gwacheon-si, South Korea, 13840, Korea
  • Websitehttps://www.jw-holdings.co.kr

Leadership

  • Mr. Kyung-Ha LeeCEO & Chairman of the Board · b. 1963
  • Mr. Seongnam ChaCo-CEO & Internal Director
  • Ji-Woo ChoiCFO & MD
  • Eun-Kyung HamManaging Director
  • Na Sook-heeInternal Director & Head of JW Management Planning Office

Financials

Income Statement

Currency: KRW2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue237.69B529.24B556.68B551.39B516.01B511.95B530.26B573.94B622.83B680.48B683.72B725.37B726.42B781.95B788.94B864.54B928.07B887.71B969.57B
Growth (%)-+122.66%+5.18%-0.95%-6.42%-0.79%+3.58%+8.24%+8.52%+9.26%+0.48%+6.09%+0.15%+7.64%+0.89%+9.58%+7.35%-4.35%+9.22%
Cost of Revenue122.24B254.57B278.55B298.07B285.32B290.28B283.60B323.38B366.31B403.21B386.41B415.46B440.29B475.50B444.76B464.58B481.91B452.49B478.10B
Gross Profit------221.25B235.68B256.51B277.27B297.31B309.91B286.13B306.44B344.18B399.96B446.16B435.22B491.47B
Gross Margin------41.73%41.06%41.19%40.75%43.48%42.72%39.39%39.19%43.63%46.26%48.07%49.03%50.69%
Operating Expense------200.83B212.18B223.05B238.28B256.07B276.61B283.40B271.95B275.45B286.62B300.78B288.45B323.57B
Operating Income11.71B45.40B51.24B41.57B13.51B3.67B20.42B23.50B33.46B38.99B41.23B33.30B2.74B34.50B68.73B113.34B145.38B146.77B167.90B
Operating Margin4.93%8.58%9.20%7.54%2.62%0.72%3.85%4.09%5.37%5.73%6.03%4.59%0.38%4.41%8.71%13.11%15.66%16.53%17.32%
EBITDA----------123.43B67.90B47.89B96.44B92.33B136.41B130.14B231.39B207.75B
EBITDA Margin----------18.05%9.36%6.59%12.33%11.70%15.78%14.02%26.07%21.43%
Net Income--1.03B---17.82B-10.94B181.41M-8.66B54.02B23.17B-33.44B10.67B-2.78B22.15B19.03B62.62B58.50B
Net Income Margin--0.19%---3.36%-1.91%0.03%-1.27%7.90%3.19%-4.60%1.37%-0.35%2.56%2.05%7.05%6.03%
R&D---10.35B27.67B-27.98B25.11B18.59B20.46B24.02B17.90B22.40B23.13B17.76B33.15B33.73B39.08B48.85B
R&D as % of Total Revenue---1.88%5.36%-5.28%4.38%2.98%3.01%3.51%2.47%3.08%2.96%2.25%3.83%3.63%4.40%5.04%
Interest Expense0000000000032.51B31.80B25.90B21.46B25.29B32.53B32.17B19.86B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.48%4.38%3.31%2.72%2.93%3.51%3.62%2.05%

Balance Sheet

Currency: KRW2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets554.89B642.09B709.64B736.86B1.09T1.08T1.01T1.04T1.08T1.20T1.35T1.28T1.24T1.12T1.07T1.16T1.18T1.25T1.23T
Total Liabilities340.17B428.10B489.21B544.41B848.16B871.67B778.42B824.06B812.56B919.04B976.65B874.64B891.84B783.76B760.96B824.32B827.51B729.21B636.56B
Total Equity130.36B131.12B107.85B84.03B99.85B77.38B105.35B95.87B103.71B116.55B167.58B181.82B149.55B146.18B93.24B106.99B123.96B229.54B266.96B
Cash15.56B23.76B14.07B10.01B9.64B9.49B11.83B14.11B15.34B53.22B41.62B74.51B115.76B30.74B46.94B60.46B73.90B44.04B71.83B
Net Debt----------688.82B516.57B461.60B484.36B428.85B483.01B454.23B367.61B265.22B

Cash Flow

Currency: KRW2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow16.24B8.28B-7.97B-861.85M-54.03B-17.18B-23.98B-29.21B10.51B195.76B98.68B108.62B109.64B104.43B112.32B97.89B163.67B
Investing Cash Flow------41.57B-1.90B-38.24B-51.03B14.62B-91.26B-21.99B-78.26B-7.64B----
Financing Cash Flow-64.13B79.00B59.64B107.43B18.85B15.29B21.21B62.98B118.86B-33.54B-73.40B-36.86B-113.18B-86.04B----
Capital Expenditure22.00B44.99B67.52B38.78B93.23B28.15B7.02B9.58B7.66B14.99B17.52B23.46B18.85B51.88B37.49B70.11B85.30B35.71B54.70B
Free Cash Flow-----------15.16B170.16B71.29B51.15B66.10B34.32B27.01B62.19B108.97B
Dividends Paid-1.74B900.00M4.02B4.32B4.34B3.94B4.12B4.09B7.20B10.15B21.58B15.63B16.00B14.48B15.42B17.74B17.17B18.53B
FCF to OCF-----------144.18%86.92%72.24%47.09%60.28%32.86%24.05%63.53%66.58%
Dividend Paid to FCF-----------66.98%12.68%21.92%31.29%21.91%44.93%65.68%27.61%17.00%

Earnings

Report DateJun 30, 2011Sep 30, 2011May 15, 2012Aug 14, 2012Nov 14, 2012Dec 31, 2012May 30, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 17, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Feb 9, 2022May 10, 2022Aug 10, 2022Nov 9, 2022Feb 8, 2023May 10, 2023Aug 9, 2023Nov 8, 2023Mar 27, 2024May 8, 2024Aug 1, 2024Nov 6, 2024Feb 11, 2025May 7, 2025Jul 30, 2025Nov 4, 2025Dec 31, 2025May 5, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------
EPS Actual-34.77-21.307.4636.54-33.89-157.16-53.05410.92-69.58-30.43-66.69-48.27-0.60-18.60-10.8515.71-4.8210.479.20-95.4453.58-93.00-29.0650.18-18.69-120.86-22.54700.58-228.41-133.71-114.52-17.1220.39-351.74-33.34-29.588.52221.0489.83-16.2548.53-165.6487.760.44130.15104.37231.49-193.8535.02184.06177.87411.96180.88105.15144.1457.38309.98328.81298.70281.03
Surprise------------------------------------------------------------
Timing--Pre-marketPre-marketPre-market-Pre-market----------------------------------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap295.44B
Enterprise Value552.95B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.29
Price / Book1.03
Revenue (TTM)1.01T
Gross Profit (TTM)522.46B
EBITDA231.02B
Profit Margin8.35%
Operating Margin20.18%
Return on Equity26.76%
Return on Assets9.30%
Shares Outstanding69.19M
Shares Float35.88M
Beta0.58
Dividend Yield4.94%
Dividend Rate215.00
Payout Ratio17.64%

Dividends

20261×
215.00Mar 31, 2026
20241×
115.00Dec 27, 2024
20231×
105.00Dec 27, 2023
20221×
95.18Dec 28, 2022
20211×
85.67Dec 29, 2021
20201×
80.75Dec 29, 2020
20191×
80.75Dec 27, 2019
20181×
74.04Dec 27, 2018
20171×
64.05Dec 27, 2017
20161×
62.79Dec 28, 2016
20151×
36.94Dec 29, 2015
20141×
19.54Dec 29, 2014
20131×
18.61Dec 27, 2013
20121×
18.61Dec 27, 2012
20111×
27.54Dec 28, 2011
20101×
27.54Dec 29, 2010
20091×
42.13Dec 29, 2009

Stock Splits

  • Dec 27, 20231.02:1
  • Mar 13, 20231.03:1
  • Dec 29, 20211.03:1
  • Dec 29, 20201.03:1
  • Dec 27, 20191.03:1
  • Dec 27, 20181.02:1
  • Dec 27, 20171.02:1
  • Dec 29, 20151.02:1
  • Dec 29, 20141.05:1
  • Dec 27, 20131.05:1
  • Dec 27, 20121.05:1
  • Dec 28, 20111.03:1
  • Oct 15, 20095:1